<- Go Home

PanGenex Corporation

As of April 8, 2008, PanGenex Corporation was acquired by Calgenex Corporation, in a reverse merger transaction. PanGenex Corp. develops and markets nutraceuticals and topical over the counter (OTC) drugs and personal care products. Its products include Calci-CLEAR, a program that helps cleanse bodies of calcium crystals; Omeganol, a supplement that combines the triglyceride-lowering properties of omega 3s with the cholesterol balancing activity of tocotrienols; and Dermallve, a lotion that relieves symptoms of chronic skin diseases. The company caters to nutraceutical and cardiovascular health industries. PanGenex is based in Tampa, Florida.

Market Cap

$30.7M

Volume

4.00

Cash and Equivalents

$13.5K

EBITDA

-$1.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$78.3K

Profit Margin

9.40%

52 Week High

$8.3K

52 Week Low

$0.12

Dividend

N/A

Price / Book Value

-562.25

Price / Earnings

-566.74

Price / Tangible Book Value

-562.25

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$1.5M

Return on Equity

121.66%

Return on Assets

-76.02

Cash and Short Term Investments

$13.5K

Debt

$1.9M

Equity

-$2.1M

Revenue

$832.7K

Unlevered FCF

-$696.0K

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches